ENOV Enovis
$18.20 -2.62%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-2.62%
YTD
-40.00%
P/E
—
P/B
1.02
ROE
-68.2%
Div yield
—
Beta
1.41
Market cap
$1.0B
RSI (14)
40
Next earnings
Nov 4, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$19.01
Close
$18.20
VWAP (n/a)
—
Day high
$19.01
Day low
$18.06
Volume
1.0M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Sports Rehabilitation Equipment Market Global Report 2026: Capitalize on a $2.05 Billion Revenue Surge to $6.84 Billion by 2030 as AI and Robotics Disrupt Recovery—Benchmark Stryker, Smith & Nephew, Enovis, Performance Health and Life Fitness
Yahoo Finance · Sep 28
3 Reasons ENOV is Risky and 1 Stock to Buy Instead
Yahoo Finance · Sep 17
Insider at Medical Device Maker Buys More Than 7,500 Shares
Yahoo Finance · Sep 14
Q2 Earnings Highlights: Enovis (NYSE:ENOV) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks
Yahoo Finance · Sep 4
What Makes Enovis (ENOV) a New Buy Stock
Yahoo Finance · Sep 3
Enovis (ENOV) Loses 33% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Yahoo Finance · Sep 3
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Sep 1, 2026 View → 10-Q Aug 6, 2026 View → 8-K Aug 6, 2026 View → 8-K May 19, 2026 View → 10-Q May 7, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell ENOV. Try it in the Lab to size a position and see the risk.